IBD Fecal Biomarkers: Scientific Findings & Clinical Applications
Your test could not be submitted for the following reasons:
Release Date: 5/11/2020
Expiration Date: 5/11/2022
: Dr.    Professor   Mr.   Mrs.   Ms.  
*:
*:
:
:
*:
:
:
*:
:
*:
*:
*:
:
The educational supporter of this program may contact me with additional information
  1. Which of the following biomarkers are specific for intestinal inflammation?
    1. Increased WBCs
    2. ESR
    3. Fecal lactoferrin
    4. CRP
  2. What percentage of adults in the U.S. may develop IBD?
    1. 0.3%
    2. 1.3%
    3. 20%
    4. 50%
  3. Which of the following characteristics defines the most ideal fecal biomarker for IBD?
    1. Should be specific for any inflammation
    2. Should be specific for intestinal inflammation
    3. Should be robust with multiple cutoffs
    4. Should be measured from frozen samples
  4. Fecal calprotectin levels may
    1. Increase in infants
    2. Decrease in high BMI
    3. Increase in functional diseases
    4. Increase in smokers
  5. Fecal lactoferrin should not be used in what group?
    1. Elderly
    2. Healthy adults
    3. Teens
    4. Infants
  6. Which of the following would indicate Crohn’s disease?
    1. Positive fecal lactoferrin and positive ASCA
    2. Positive fecal lactoferrin and negative ASCA
    3. Positive fecal lactoferrin alone
    4. Positive calprotectin alone
  7. The gold standard for IBD diagnosis is
    1. Serum biomarker identification
    2. X-ray imaging
    3. Endoscopy with histology
    4. Clinical assessment
  8. Fecal biomarkers calprotectin and lactoferrrin are recommended for
    1. Diagnosis and management of CD and UC
    2. Management of IBS
    3. Diagnosis of other intestinal diseases
    4. Diagnosis and management of any inflammatory disease
  9. These fecal biomarkers are more sensitive and specific for IBD than serum markers
    1. Calprotectin
    2. Lactoferrin
    3. Fecal ASCA
    4. All of the above
  10. Elevated fecal lactoferrin levels are associated with
    1. IBD recurrence
    2. IBD remission
    3. IBS remission
    4. IBS treatment
  11. The information was clear and to the point.
    1. strongly agree
    2. agree
    3. uncertain
    4. disagree
    5. strongly disagree
  12. The material met my educational objectives.
    1. strongly agree
    2. agree
    3. uncertain
    4. disagree
    5. strongly disagree
  13. The information provided will be useful in my practice.
    1. strongly agree
    2. agree
    3. uncertain
    4. disagree
    5. strongly disagree
  14. The education was free of commercial bias.
    1. strongly agree
    2. agree
    3. uncertain
    4. disagree
    5. strongly disagree
:
:
:
Planned and developed by Medavera and supported by an educational donation from TechLab, Inc.
©2020 Medavera. All rights reserved.
Inquiries: info@medavera.com